med. pract. Roberto Rodriguez

• A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study. Rubio IT, Rodriguez-Revuelto, R, Espinosa-Bravo M, Siso C, Rivero J, Esgueva AJ. European Journal of Surgical Oncology 2020
• Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries. Esgueva A, Rodríguez-Revuelto R, Espinosa-Bravo M, Salazar JP, Rubio IT. European Journal of Surgical Oncology. 2019
• Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA trial). A new tool to guide the excision of the clipped node after neoadjuvant treatment. Siso C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, Rus N, Cordoba O, Rodriguez R, Peg V, Rubio IT. Annals of Surgical Oncology. 25-3, pp. 784-791. 2018
• Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution. Cortadellas T, Cordoba O, Gascon A, Haladjian C, Bernabeu A, Alcalde A, Esgueva A, Rodriguez-Revuelto R, Espinosa-Bravo M, Diaz-Botero S, Xercavins J, Rubio IT. Moreno-Gil A. European Journal of Surgical Oncology. 41-5, pp. 635-640. 2015.
• The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Rubio IT, Diaz-Botero S, Esgueva A, Rodriguez R, Cortadellas, Cordoba O, Espinosa-Bravo M. European Journal of Surgical Oncology. 41-1, pp. 46-51. 2015.
• Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery. Cordoba O, Perez-Ceresuela F, Espinosa Bravo M, Cortadellas T, Esgueva A, Rodríguez-Revuelto R, Peg V, Reyes V, Xercavins J, Rubio IT. Breast. 23-4, pp. 460-465. 2014.
• Surgery improves breast cancer-specific survival in octogenarians with early-stage breast cancer. Cortadellas T, Gascon A, Cordoba O, Rabasa J, Rodriguez R, Espinosa-Bravo M, Esgueva A, Rubio IT, Xercavins J, Gil A. International Journal of Surgery. 11-7, pp. 554-557. 2013.
• Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study. Dopazo C, Rodriguez R, Llado L, Calatayud D, Castells L, Ramos E, Molina V, Garcia R, Fabregat J, Charco R. Clinical Transplantation. 26-1, pp. 32-37. 2012.
• Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Sapisochin G, Bilbao I, Dopazo C, Castells L, Lazaro JL, Rodriguez R, Caralt M, Blanco L, Balsells J, Charco R. Hepatology International. 5-2, pp. 707-715. 2011.
• Post-pancreaticoduodenectomy hemorrhage. Incidence, diagnosis, and treatment. Mañas-Gomez MJ, Rodriguez-Revuelto R, Balsells-Valls J, Olsina-Kissler JJ, Caralt-Barba M, Perez-Lafuente M, Charco-Torra R. World Journal of Surgery. 35-11, pp. 2543-2548. 2011.

Nationale und internationale wissenschaftliche Kommunikation

• Comparison of different doses of superparamagnetic iron oxide for sentinel node biopasy in breast cancer: the superparamagnetic iron oxide for sentinel node in breast cancer: Sunrise radomized trial. 38th Congress of the European Society of Surgical Oncology. 10-12th October 2018. Budapest, Hungary.
• Intraoperative ultrasound guided surgery after neoadjuvant treatment in breast cancer improves patients’ quality of life. 2017 Sant Antonio Breast Symposium. 5-9th December 2017. Sant Antonio, Texas, USA.
• Breast cancer patients undergoing mastectomy and immediate breast reconstruction: Does BRCA carriers different outcomes? 36th Congress of the European Society of Surgical Oncology. 14th September 2016. Krakow, Poland.
• Assessing the risk of patients with positive sentinel lymph nodes by70-gene signature spare them from adjuvant systemic chemotherapy: a population-based, observational study. 2nd World Congress on controversies in breast cancer (CoBrCa). 8th September 2016. Barcelona, Spain.
• Quality assurance in breast cancer surgery. Reinterventions following breast-conserving surgery (Control de calidad en la cirugía del cáncer de mama. Reintervenciones después de la cirugía conservadora de la mama). 5th Congress of the Spanish Association of Breast Surgeons (AECIMA). 14th May 2016. Las Palmas de Gran Canaria, Canary Islands, Spain.
• Pronostic effect of immunophenotype in ephitelial tumors of the breast in young patients (Efecto pronóstico del inmunofenotipo de los tumores epiteliales de mama en mujeres jóvenes). 31st National Meeting of the Spanish Society of Gynaecology and Obstetrics (SEGO). 26th October 2012. Sevilla, Spain.
• Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study. 15th Congress of the European Society for Organ Transplantation & 22nd Annual BSHI Conference. 4th September 2011. Glasgow, UK.
• Does late recurrence after hepatectomy for HCC impact on survival after liver transpalantation for HCC recurrence? A case report. 15th Congress of the European Society for Organ Transplantation and 22nd Annual BSHI Conference. 4th September 2011. Glasgow, UK.
• The impact of everolimus based immunosupression on HCV recurrence after liver transplantation: case-control study. 15th Congress of the European Society for Organ Transplantation and 22nd Annual BSHI Conference. 4th September 2011. Glasgow, UK.
• The impact of everolimus based immunosupression on HCV recurrence after liver transplantation: case-control study. Joint International Congress of ILTS, ELITA and LICAGE. 22nd June 2011. Valencia, Spain.
• Application of BCLC staging system for patients with hepatocellular carcinoma (HCC) before 1999. Does it affect prognosis? 16th Annual International Congress of International Liver Transplantation Society. 16th June 2010, Hong Kong, China.
• Evolution and management of de novo neoplasms after liver transplantation. A 20 year experience in a single European series. 16th Annual International Congress of International Liver Transplantation Society. 16th June 2010, Hong Kong, China.
• Evolution of biliary complications after liver transplantation. 20 years experience from a single European series. 16th Annual International Congress of International Liver Transplantation Society. 16th June 2010, Hong Kong, China.
• Evolution of biliary complications after liver transplantation. 20 years experience from a single European series. 9th Congress of the International Hepato-Pancreato-Biliary Association. 18th April 2010. Buenos Aires, Argentina.
• Long-term outcome of patients with intermediate hepatocellular carcinoma. Where is the role of liver resection? 9th Congress of the International Hepato-Pancreato-Biliary Association. 18th April 2010. Buenos Aires, Argentina.
• Role of liver resection in succesful long-term survival of patients with cancer developing late hepatic metastasis. 9th Congress of the International Hepato-Pancreato-Biliary Association. 18th April 2010. Buenos Aires, Argentina.
• The impact of diabetes mellitus in long-term outcome of liver transplant for hepatitis C. 14th Congress of the European Society for Organ Transplantation. 30th August 2009. Paris, France.
• Our experience in liver transplant patients older than 65 years old. 7th World Congress of IHPBA and 10th Annual Meeting of AUGIS. 3rd September 2006. Endinburgh, United Kingdom.